Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지

Interleukin-8 production and interleukin-8 mRNA expression induced by lipopolysaccharides from Prevotella intermedia and Prevotella nigrescens in monocyte-derived macrophages

Prevotella intermedia 및 Prevotella nigrescens의 지질다당질이 대식 세포에서의 Interleukin-8 생성에 미치는 영향

  • Kim, Sung-Jo (Department of Periodontology, College of Dentistry, Pusan National University)
  • 김성조 (부산대학교 치과대학 치주과학교실)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Interleukin-8 (IL-8) is an important mediator of immune and inflammatory reactions and is produced by a variety of different cell types. This study was undertaken to investigate the effects of lipopolysaccharides (LPSs) from Prevotella intermedia and Prevotella nigrescens, the major causes of inflammatory periodontal disease, on the production of IL-8 and the expression of IL-8 mRNA in differentiated THP-1 cells, a human monocytic cell line. Methods: LPSs from P. intermedia ATCC 25611 and P. nigrescens ATCC 33563 were prepared by the standard hot phenol-water method. THP-1 cells were incubated in the medium supplemented with phorbol myristate acetate to induce differentiation into macrophage-like cells. Results: We found that LPS preparations from P. intermedia and P. nigrescens can induce IL-8 mRNA expression and stimulate the release of IL-8 in differentiated THP-1 cells without additional stimuli. Conclusions: There are no previous reports of the ability of P. intermedia and P. nigrescens LPS to stimulate the release of IL-8, and the present study clearly shows, for the first time, that LPSs from P. intermedia and P. nigrescens fully induced IL-8 mRNA expression and IL-8 production in differentiated human monocytic cell line THP-1. The ability of P. intermedia and P. nigrescens LPS to promote the production of IL-8 may be important in the pathogenesis of inflammatory periodontal disease.

Keywords

References

  1. Zambon JJ. Periodontal diseases: microbial factor. Ann Periodontol 1996;1:879-925 https://doi.org/10.1902/annals.1996.1.1.879
  2. Slots J, Bragd L, Wikstrom M, Dahlen G. The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol 1986;13:570-577 https://doi.org/10.1111/j.1600-051X.1986.tb00849.x
  3. Tanner ACR, Haffer C, Bratthall GT, Visconti RA, Socransky SS. A study of the bacteria associated with advancing periodontitis in man. J Clin Periodontol 1979;6:278-307 https://doi.org/10.1111/j.1600-051X.1979.tb01931.x
  4. Chung CP, Nisengard RJ, Slots J, Genco RJ. Bacterial IgG and IgM antibody titers in acute necrotizing ulcerative gingivitis. J Periodontol 1983;54:557-562 https://doi.org/10.1902/jop.1983.54.9.557
  5. Kornman KS, Loesche WJ. The subgingival microbial flora during pregnancy. J Periodont Res 1980;15:111-122 https://doi.org/10.1111/j.1600-0765.1980.tb00265.x
  6. Lie MA, van der Weijden GA, Timmerman MF, Loos BG, van Steenbergen TJM, van der Velden U. Occurrence of Prevotella intermedia and Prevotella nigrescens in relation to gingival health. J Clin Periodontol 2001;28:189-193 https://doi.org/10.1034/j.1600-051x.2001.028002189.x
  7. Ximenez-Fyvie LA, Haffajee AD , Socransky SS. Microbial composition of supra and subgingival plaque in subjects with adult periodontitis. J Clin Periodontol 2000;27:722-732 https://doi.org/10.1034/j.1600-051x.2000.027010722.x
  8. Teanpaisan, R, Douglas CW and Walsh TF. Characterization of black-pigmented anaerobes isolated from diseased and healthy periodontal sites. J Periodont Res 1995;30:245-251 https://doi.org/10.1111/j.1600-0765.1995.tb02129.x
  9. Bae KS, Baumgartner JC, Shearer TR, David LL. Occurrence of Prevotella nigrescens and Prevotella intermedia in infections of endodontic origin. J Endod 1997;23;620-623 https://doi.org/10.1016/S0099-2399(97)80173-2
  10. Salcetti JM, Moriarty JD, Cooper LF et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants 1997;12:32-42
  11. Simon BI, Goldman HM, Ruben MP, Baker E. The role of endotoxin in periodontal disease. I. A reproducible, quantitative method for determining the amount of endotoxin in human gingival exudate. J Periodontol 1969;40:695-701 https://doi.org/10.1902/jop.1969.40.12.695
  12. Shapiro L, Lodato FM Jr, Courant PR, Stallard RE. Endotoxin determination in gingival inflammation. J Periodontol 1972;43:591-596 https://doi.org/10.1902/jop.1972.43.10.591
  13. Maidwell-Smith MA, Wilson M, Kieser JB Lipopolysaccharide (endotoxin) from periodontally involved teeth. J Clin Periodontol 1987;14:453-456 https://doi.org/10.1111/j.1600-051X.1987.tb02250.x
  14. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med 1987;38:417-432 https://doi.org/10.1146/annurev.me.38.020187.002221
  15. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242 https://doi.org/10.1146/annurev.immunol.18.1.217
  16. Baggiolini M. Chemokines in pathology and medicine. J Int Med 2001;250:91-104 https://doi.org/10.1046/j.1365-2796.2001.00867.x
  17. Wuyts A, Proost P, Damme J. Interleukin-8 and other CXC chemokines. In: Thomson A, ed. The cytokine handbook, 3rd edn., Chapter 10. London: Academic Press, 1988
  18. Thelen M, Peveri P, Kernen P, von Tscharaner V, Walz A, Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988;2:2702-2706 https://doi.org/10.1096/fasebj.2.11.2840318
  19. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988;167:1547-1559 https://doi.org/10.1084/jem.167.5.1547
  20. Detmers PA, Lo SK, Olsen EE et al. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990;171:1155-1162 https://doi.org/10.1084/jem.171.4.1155
  21. Westphal O, Jann K. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. In: RL Whistler eds. Methods in carbohydrate chemistry. New York: Academic Press, 1965:83-91
  22. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978;87:206-210 https://doi.org/10.1016/0003-2697(78)90586-9
  23. Hamada S, Takada H, Ogawa T, Fujiwara T, Mihara J. Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. Int Rev Immunol 1990;6:247-261 https://doi.org/10.3109/08830189009056635
  24. Kirikae T, Nitta T, Kirikae F, Suda Y, Kusumoto S, Qureshi N & Nakano M. Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infect Immun 1999;67:1736-1742
  25. Fitzgerald JE, Kreutzer DL. Localization of interleukin-8 in human gingival tissues. Oral Microbiol Immunol 1995;10:297-303 https://doi.org/10.1111/j.1399-302X.1995.tb00158.x
  26. Tonetti MS, Imboden MA, Gerber L, Lang NP, Laissue J, Mueller C. Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect Immun 1994;62:4005-4014
  27. Tamura M, Tokuda M, Nagaoka S, Takada H. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect Immun 1992;60:4932-4937
  28. Darveau RP, Belton CM, Reife RA, Lamont RJ. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 1998;66:1660-1665
  29. Madianos PN, Papapanou PN, Sandros J. Porphyromonas gingivalis infection of oral eputhelium inhibits neutrophil transepithelial migration. Infect Immun 1997;65:3983-3990
  30. Watanabe A, Takeshita A, Kitano S, Hanazawa S. CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun 1996;64:4488-4494
  31. Shah HN, Gharbia SE. Proposal of a new species Prevotella nigrescens sp. nov. among strains previously classified as P. intermedia. FEMS Immunol Med Microbiol 1993;6:97 https://doi.org/10.1111/j.1574-695X.1993.tb00309.x
  32. Okamoto M, Maeda N, Kondo K, Leung KP. Hemolytic and hemagglutinating activities of Prevotella intermedia and Prevotella nigrescens. FEMS Microbiol Lett 1999;178:299-304 https://doi.org/10.1111/j.1574-6968.1999.tb08691.x
  33. Matto J, Asikainen S, Vaisanen ML et al. Beta-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents. Antimicrob Agents Chemother 1999;43:2383-2388
  34. Andres MT, Chung WO, Roberts MC, Fierro JF. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother 1998;42:3022-3023